The AHA, Association of American Medical Colleges, America’s Essential Hospitals, Eastern Maine Healthcare Systems, Henry Ford Health System and Adventist Health System's Park Ridge Health yesterday urged a federal appeals court to find that they are entitled to a preliminary injunction in their lawsuit to prevent a nearly 30% Medicare payment reduction for many hospitals in the 340B drug savings program. In their brief, they seek remand of this case back to the trial court with a specific instruction from the appeals court to enter the injunction. At a minimum, the injunction would direct the Department of Health and Human Services to set outpatient prospective payment system payment rates for calendar year 2019 without the nearly 30% reduction and at the level needed to correct the past effects of the reduction. The lower court on Dec. 29 dismissed the lawsuit as premature, without ruling on the merits of the groups’ claim that the HHS Secretary exceeded his statutory authority in making the payment reduction. Today’s filing concludes all briefing in the appeal. The court has scheduled oral arguments for May 4.  
 

Related News Articles

Headline
Health Insurance Marketplace insurers will propose a median premium increase of 15% for 2026, according to an analysis of preliminary rate filings published…
Headline
An analysis published July 14 by KFF found that use of the 988 Suicide and Crisis Lifeline has steadily increased since its launch in July 2022. To date, the…
Headline
The Centers for Medicare & Medicaid Services July 17 issued two letters to states regarding policies on continuous eligibility and workforce initiatives.…
Headline
The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
Gilchrist in Baltimore and Bristol Hospice — Hawaii are winners of the AHA 2025 Circle of Life Award for their efforts in palliative and end-of-life care. The…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…